PCRX vs AVDL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

PCRX

53.3
AI Score
VS
PCRX Wins

AVDL

48.4
AI Score

Investment Advisor Scores

PCRX

53score
Recommendation
BUY

AVDL

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PCRX AVDL Winner
Forward P/E 6.25 16.835 PCRX
PEG Ratio 11.2121 0.07 AVDL
Revenue Growth 6.2% 54.9% AVDL
Earnings Growth -30.0% 0.0% AVDL
Tradestie Score 53.3/100 48.4/100 PCRX
Profit Margin 2.0% -0.1% PCRX
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD PCRX

Relative Price Performance (Last 90 Days)

PCRX 1M: -5.2% · 3M: -1.5% AVDL 1M: +0.7% · 3M: +15.8%

Current Technical Phase

PCRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.7 · Price: $25.21

AVDL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.4% over 20 days), RSI 62

RSI (14): 62.3 · Price: $21.64

Fundamentals Snapshot

Metric PCRX AVDL
Market Cap — —
Forward P/E 7.3 28.8
Trailing P/E 71.5 0.0
Revenue (TTM) — —
Revenue Growth 0.1% 0.5%
Gross Margin 0.8% 0.9%
Operating Margin 0.1% 0.0%
EPS 0.35 0.00
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.